"As a practicing cardiologist and a clinician-scientist, Core Three provides me not only with updates in the clinical management of children and adults with complex heart disease, but it also highlights groundbreaking discoveries in cardiovascular genetics and genomics."
- Seema Mital, M.D., FACC, FAHA, FRCPC
Associate Professor of Pediatrics, University of Toronto
Staff Cardiologist, Hospital for Sick Children
"As a genetics and pharmacogenetics researcher, Core Three programming pulls together the important advances in genetics and pharmacogenetics research, providing an excellent opportunity to stay at the forefront of research in this area."
- Julie A. Johnson, Pharm.D.
Professor and Chair, Dept of Pharmacotherapy and Translational Research
Director, UF Center for Pharmacogenomics
V. Rave Chandran Professor of Pharmaceutical Sciences
"Arrhythmias and sudden cardiac death are responsible for enormous cardiovascular morbidity and mortality. The content in Core Four includes cutting edge basic, translational, clinical and population science focused on diminishing the burden of arrhythmic diseases."
- Glenn I. Fishman, M.D., FAHA Director, Division of Cardiology
New York University School of Medicine
Core Five Programming
"As a basic and translational scientist studying cardiac signaling in hypertrophy and heart failure, I follow sessions in Core Five so I can learn the latest research dealing with myocardial regulation."
- Walter J. Koch, Ph.D., FAHA
W.W. Smith Professor of Medicine, Thomas Jefferson University
“I am excited to learn about the latest innovations in cardiovascular interventions and surgery at the AHA Core Six.” - Y. Joseph Woo, M.D.
Associate Professor of Surgery
Director, Minimally Invasive and Robotic Cardiac Surgery Program